Does TREPROSTINIL Cause Thrombophlebitis superficial? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Thrombophlebitis superficial have been filed in association with TREPROSTINIL (TYVASO). This represents 0.0% of all adverse event reports for TREPROSTINIL.
8
Reports of Thrombophlebitis superficial with TREPROSTINIL
0.0%
of all TREPROSTINIL reports
0
Deaths
6
Hospitalizations
How Dangerous Is Thrombophlebitis superficial From TREPROSTINIL?
Of the 8 reports, 6 (75.0%) required hospitalization, and 1 (12.5%) were considered life-threatening.
Is Thrombophlebitis superficial Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Thrombophlebitis superficial?
DROSPIRENONE\ETHINYL ESTRADIOL (160)
LENALIDOMIDE (121)
ETHINYL ESTRADIOL\ETONOGESTREL (93)
RIVAROXABAN (82)
YAZ (78)
YASMIN (65)
TESTOSTERONE (62)
HUMAN IMMUNOGLOBULIN G (43)
ADALIMUMAB (40)
CAPECITABINE (29)
Which TREPROSTINIL Alternatives Have Lower Thrombophlebitis superficial Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE